Part II: Translational Pathway for Devices
Click/Tap a chapter title to enter
| II.1 | Regulatory Pathway for 510k, IDE, and PMA |
| Deborah G Castillo PhD, Bram Zuckerman MD and Felipe Aguel PhD | |
| II.2 | EU Regulatory Frameworks for Medicines and Medical Devices for Cardiovascular Disease |
| Peter Feldschreiber LLB and Alasdair Breckenridge MD | |
| II.3 | Product Development of Devices |
| Robert E Kohler MS | |
| II.4 | Large Animal Models for Cardiovascular Device Development |
| Yanping Cheng MD, Daniel Burkhoff MD PhD and Juan Granada MD |
|
| II.5 | Translational Platform for Aortic Valve Replacement |
| Alain Cribier MD | |
| II.6 | Translational Pathway for Tissue Engineered Aortic Valves |
| Jerome Sohier PhD, Adrian H Chester BSC PhD and Sir Magdi H Yacoub MD |
|
| II.7 | Translational Platform for Mitral Valve Repair and Replacement |
| David G Reuter MD PhD and Patrick M Sullivan MD | |
| II.8 | Electrophysiology: Translational Research Platforms |
| Fu Siong Ng PhD, Michael T Debney and Nicholas S Peters MD | |
| II.9 | The Translational Pathway for Mechanical Circulatory Support |
| Toshinobu Kazui MD PhD, Tia Pilikian MS, Destiny Lagrand BA, Richard G Smith MSEE CCE, Sir Magdi H Yacoub MD and Zain Khalpey MD PhD |